Clinical Trial Update: Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update announcing recruitment for a combination of D07001-Softgel Capsules with Xeloda (capecitabine) or TS-1 in patients with advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• D07001 Softgel-Capsules
• TS-1 (tegafur/gimeracil/oteracil)
• Xeloda (capecitabine)

Snippet

Sponsor: InnoPharmax Inc. | Conditions: Biliary Tract Cancer | Phase 2, Phase 3 | Status: RECRUITING